A delta wave in a healthy Swiss conscript: one does not always have to burn to learn.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 20230471)

Published in Pacing Clin Electrophysiol on October 01, 2010

Authors

Michael Kühne1, Peter Ammann, Beat Schaer, Christian Sticherling, Stefan Osswald

Author Affiliations

1: Division of Cardiology, University of Basel Hospital, Petersgraben 4, Basel, Switzerland. kuehnem@uhbs.ch

Articles by these authors

Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol (2006) 6.07

Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N Engl J Med (2015) 6.00

One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch Intern Med (2012) 4.24

Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation (2011) 3.72

Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trial. JAMA (2003) 3.40

Idiopathic spontaneous coronary artery dissection: incidence, diagnosis and treatment. Int J Cardiol (2005) 3.00

High-sensitivity cardiac troponin in the distinction of acute myocardial infarction from acute cardiac noncoronary artery disease. Circulation (2012) 2.94

Necessity for surgical revision of defibrillator leads implanted long-term: causes and management. Circulation (2008) 2.82

Early and late increased bleeding rates after angioplasty and stenting due to combined antiplatelet and anticoagulanttherapy. EuroIntervention (2009) 2.74

Role of defibrillation threshold testing in the contemporary defibrillator patient population. J Cardiovasc Electrophysiol (2012) 2.67

Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study. Circulation (2008) 2.57

Raised cardiac troponins. BMJ (2004) 2.51

Introduction of high-sensitivity troponin assays: impact on myocardial infarction incidence and prognosis. Am J Med (2012) 2.14

Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET). Lancet (2005) 1.66

Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. Chest (2006) 1.65

Longevity of implantable cardioverter-defibrillators, influencing factors, and comparison to industry-projected longevity. Heart Rhythm (2009) 1.63

End-of-life preferences of elderly patients with chronic heart failure. Eur Heart J (2011) 1.61

Cost-effectiveness of invasive versus medical management of elderly patients with chronic symptomatic coronary artery disease. Findings of the randomized trial of invasive versus medical therapy in elderly patients with chronic angina (TIME). Eur Heart J (2004) 1.60

Interpretation of erythropoietin levels in patients with various degrees of renal insufficiency and anemia. Kidney Int (2004) 1.59

Risk stratification in patients with acute chest pain using three high-sensitivity cardiac troponin assays. Eur Heart J (2013) 1.58

Comparison of costs and safety of a suture-mediated closure device with conventional manual compression after coronary artery interventions. Catheter Cardiovasc Interv (2002) 1.58

Fluctuation of left ventricular thresholds and required safety margin for left ventricular pacing with cardiac resynchronization therapy. Europace (2009) 1.56

Incidence, clinical predictors, and prognostic impact of worsening renal function in elderly patients with chronic heart failure on intensive medical therapy. Am Heart J (2012) 1.52

Arrhythmogenic right ventricular cardiomyopathy: diagnostic and prognostic value of the cardiac MRI in relation to arrhythmia-free survival. Int J Cardiovasc Imaging (2003) 1.49

Impact of a lead glass screen on scatter radiation to eyes and hands in interventional cardiologists. Catheter Cardiovasc Interv (2006) 1.48

N-terminal pro-B-type natriuretic peptide and functional capacity in patients with obstructive sleep apnea. Sleep Breath (2008) 1.45

Pacemaker implantation and need for ventricular pacing during follow-up after transcatheter aortic valve implantation. Pacing Clin Electrophysiol (2014) 1.45

Quantifying cardiac hemodynamic stress and cardiomyocyte damage in ischemic and nonischemic acute heart failure. Circ Heart Fail (2011) 1.44

Effects of physical exercise on cardiac dyssynchrony in patients with impaired left ventricular function. Europace (2010) 1.42

Fever and night sweats in a 22-year-old man with a mediastinal mass involving the heart. Chest (2003) 1.29

Rapid rule out of acute myocardial infarction using undetectable levels of high-sensitivity cardiac troponin. Int J Cardiol (2013) 1.29

Statin-induced immunomodulatory effects on human T cells in vivo. Atherosclerosis (2004) 1.19

Cardiac resynchronization therapy in chronic heart failure. Swiss Med Wkly (2006) 1.11

Cryoballoon versus radiofrequency catheter ablation of paroxysmal atrial fibrillation: biomarkers of myocardial injury, recurrence rates, and pulmonary vein reconnection patterns. Heart Rhythm (2010) 1.11

A proton leak current through the cardiac sodium channel is linked to mixed arrhythmia and the dilated cardiomyopathy phenotype. PLoS One (2012) 1.07

Diagnostic and prognostic impact of copeptin and high-sensitivity cardiac troponin T in patients with pre-existing coronary artery disease and suspected acute myocardial infarction. Heart (2012) 1.06

Methadone-induced Torsade de pointes tachycardias. Swiss Med Wkly (2005) 1.06

Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study. Ann Intern Med (2010) 1.03

A novel SCN5A mutation, F1344S, identified in a patient with Brugada syndrome and fever-induced ventricular fibrillation. Cardiovasc Res (2006) 1.01

Normal presenting levels of high-sensitivity troponin and myocardial infarction. Heart (2013) 1.01

QT dispersion and heart rate variability in sudden death risk stratification in patients with ischemic heart disease. Medicina (Kaunas) (2006) 1.00

An electrocardiogram-based algorithm to detect loss of left ventricular capture during cardiac resynchronization therapy. Ann Intern Med (2005) 0.99

Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS). Europace (2015) 0.99

Amiodarone-induced thyrotoxicosis: clinical course and predictors of outcome. J Am Coll Cardiol (2007) 0.95

Validation of a novel spiral mapping catheter for real-time recordings from the pulmonary veins during cryoballoon ablation of atrial fibrillation. Heart Rhythm (2012) 0.95

Impact of the exercise mode on exercise capacity: bicycle testing revisited. Chest (2005) 0.94

Cost-effectiveness of drug-eluting stents in patients at high or low risk of major cardiac events in the Basel Stent KostenEffektivitäts Trial (BASKET): an 18-month analysis. Lancet (2007) 0.94

Markers of plaque instability in the early diagnosis and risk stratification of acute myocardial infarction. Clin Chem (2011) 0.94

Continuous positive airway pressure improves exercise capacity and heart rate recovery in obstructive sleep apnea. Int J Cardiol (2008) 0.93

Impact of the exercise mode on heart rate recovery after maximal exercise. Eur J Appl Physiol (2008) 0.92

Entering through the back-door: remotely navigated ablation of left atrial tachycardia in the presence of a large atrial septal defect occluder. Europace (2013) 0.91

Comparison of the performances of cardiac troponins, including sensitive assays, and copeptin in the diagnostic of acute myocardial infarction and long-term prognosis between women and men. Am Heart J (2013) 0.91

Right atrial pacing impairs cardiac function during resynchronization therapy: acute effects of DDD pacing compared to VDD pacing. J Am Coll Cardiol (2005) 0.90

A novel nonsense mutation in the SCN5A gene leads to Brugada syndrome and a silent gene mutation carrier state. Can J Cardiol (2005) 0.89

Elevated cardiac troponin I in sepsis and septic shock: no evidence for thrombus associated myocardial necrosis. PLoS One (2010) 0.89

Electrical storm caused by complementary medication with Ginkgo biloba extract. Am J Med (2008) 0.88

Bland-White-Garland syndrome in a 39-year-old mother. Ann Thorac Surg (2004) 0.88

Phrenic nerve palsy during ablation of atrial fibrillation using a 28-mm cryoballoon catheter: predictors and prevention. J Interv Card Electrophysiol (2012) 0.87

Clinical characteristics, sex hormones, and long-term follow-up in Swiss postmenopausal women presenting with Takotsubo cardiomyopathy. Clin Cardiol (2012) 0.87

Functional assessment of the left atrium by real-time three-dimensional echocardiography using a novel dedicated analysis tool: initial validation studies in comparison with computed tomography. Eur J Echocardiogr (2011) 0.87

Close connection between improvement in left ventricular function by cardiac resynchronization therapy and the incidence of arrhythmias in cardiac resynchronization therapy-defibrillator patients. Eur J Heart Fail (2010) 0.86

Prognostic value of self-reported versus objectively measured functional capacity in patients with heart failure: results from the TIME-CHF (Trial of Intensified Versus Standard Medical Therapy in Elderly Patients with Congestive Heart Failure). J Am Coll Cardiol (2012) 0.86

Effect of implantable cardioverter-defibrillator on left ventricular ejection fraction in patients with idiopathic dilated cardiomyopathy. Am J Cardiol (2010) 0.86

Remote monitoring of cardiovascular implantable electronic devices: prerequisite or luxury? Swiss Med Wkly (2009) 0.86

Cryoballoon ablation for pulmonary vein isolation in patients with paroxysmal atrial fibrillation. Swiss Med Wkly (2010) 0.85